// App-Quantinova.ai

5185 : Development of patient-derived xenograft (PDX) models for pancreatic carcinoma as a preclinical platform for drug development

Researchers

Presenter

  • Jill Ricono

Principal Investigators

  • Jayant Thatte

  • Colleen Scott

  • Thomas B. Broudy

Medical Centers

  • Crown Bioscience San Diego, San Diego, CA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Pancreas ductal adenocarcinoma

  • Pancreatic cancer

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Gemcitabine

  • Protein-bound paclitaxel

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A